Rebecca Tollervey - March 11, 2025 Innovations in antibody-drug conjugates and bispecific antibodies – what you need to know - a new special report We are delighted to release our latest report Innovations in antibody-drug conjugates and ...
Tanis Keirstead - April 14, 2022 Horizons in vaccine production The scramble for a coronavirus vaccine over the last two years has demonstrated how important ...
Tanis Keirstead - April 4, 2022 A much-needed boost: the future of coronavirus vaccines Just over two years after our first blog on Covid-19, it appears that the disease is here to stay. ...
Tanis Keirstead - September 8, 2021 A Unified Patents Court in 2022? The next hurdle in the way of the Unified Patent Court (UPC) opening its doors has now been ...
Tanis Keirstead - December 14, 2020 New appointments signal rapid growth for Mewburn Ellis in Munich We have continued to demonstrate impressive growth with a series of new hires in our Munich office ...
Tanis Keirstead - November 27, 2020 Further constitutional challenges to Unified Patent Court Agreement On 26 November 2020, the German Bundestag approved the ratification bill for the Unified Patent ...
Tanis Keirstead - June 5, 2020 Links between COVID-19 severity and the immune system The mechanism through which SARS-CoV-2, the virus that causes COVID-19, infects cells is known. The ...
Tanis Keirstead - March 26, 2020 German Constitutional Court Verdict: Stumbling Block or Death Knell for the UPC? On 20 March 2020, three years after the challenge was originally brought, the German Constitutional ...
Tanis Keirstead - March 24, 2020 Coronavirus (COVID-19): a case study in emerging disease UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production, we explore pressing need to ...
Tanis Keirstead - September 19, 2019 Obtaining patent protection for fermentation processes and products – the European perspective Fermented foods have been known for millennia and form an important part of many national cuisines. ...
